EUR/USD recently hit a one-month high before pulling back to 1.1380 support. A rebound may test the trend line near 1.1320 before moving higher. Key resistance remains at the recent high around 1.1580 ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the pharmaceutical industry. But Trump’s tariffs on the sector, if imposed, could worsen ...

A new study suggests a slightly modified standard model explains the COVID crash and recovery. Maybe the pandemic didn't ...

The United Kingdom's stock market has recently experienced a downturn, with the FTSE 100 and FTSE 250 indices both closing lower amid concerns over weak trade data from China, highlighting global ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

European stocks closed weak on Monday as rising trade tensions due to China and the U.S. accusing each other of violating trade agreement, and the Trump administration's ...

European shared slipped 0.1 per cent on Monday starting to start June in the red, despite recording a 4 per cent gain in May, as investors reacted late to further US import tariffs late on Friday. The ...

Asandeutertinib is a derivative of Tagrisso designed to avoid certain toxic side effects in patients with EGFR-mutated NSCLC.

Indian equities closed flat on Monday as IT and metal losses outweighed optimism from strong GDP data. Market consolidation ...

Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE: AZN) have released detailed Phase III results that could help position their ...

Postoperative nivolumab added to standard-of-care adjuvant cisplatin radiotherapy “represents a potential new standard.” ...